Tag: symbol: RHHBY

What Happened: Jim Cramer outlined fresh investment prospects on Monday, revolving around the growing demand for GLP-1 drugs, typically administered for diabetes and obesity treatment. As reported by CNBC, investors…

The U.S. Food and Drug Administration has recently issued a stern warning to the public, advising against the purchase and use of multiple specific over-the-counter eye drop products from prominent brands.  The agency…